This episode of the SmartMoney Ventures Podcast features Dr. Michael Triplett, CEO of Myonexus Therapeutics who, along with co-founder Dr. Louise Rodino-Klapac, successfully completed a 9 figure exit event before securing Series A financing.
The story illustrates how successful tech transfer and strategic positioning resulted in the establishment of a new Gene Therapy Center of Excellence creating over 100 new jobs while transforming Muscular Dystrophy patient treatments.
Prior to co-founding Myonexus, Michael held leadership positions at Proctor & Gamble, Battelle Memorial Institute and Ventaira Pharmaceuticals among others.
In this episode, you will learn:
- How to get a 9 figure exit before your Series A financing
- How Technology Transfer is transforming the Heartland Region
- Why resilience is a big part of entrepreneurial psychology
- Sage advice for technical & scientific founders
- How a Gene Therapy Center of Excellence was established in Central Ohio
Dr. Triplett holds both a bachelor’s degree and a Ph.D. in Chemical Engineering from THE Ohio State University graduating Summa Cum Laude.
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
The Breakfast Club
The World's Most Dangerous Morning Show, The Breakfast Club, With DJ Envy, Jess Hilarious, And Charlamagne Tha God!